Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 176 clinical trials
The SOLID Platelet Study

Background Platelets are cell fragments in the blood that help it clot. Some people get very low platelet counts during a disease or treatment. Low platelet counts can cause severe bleeding. Some people are not helped by platelet transfusions at the standard transfusion rate. This is called platelet transfusion refractoriness …

platelet count
hematologic malignancy
blood transfusion
platelet transfusion refractoriness
pulmonary hemorrhage
  • 0 views
  • 25 Jul, 2022
  • 1 location
Post IVIG Medication in Children With Immune Thrombocytopenia

This study is a single hospital system, single-arm year-long pilot to evaluate the feasibility of enrolling children with ITP who are receiving IVIG for treatment of disease to a scheduled post-infusion medication for 72 hours following IVIG infusion. This year-long feasibility pilot will test the (1) feasibility of enrollment and …

thrombocytopenia
treatment regimen
igiv
blood tests
  • 0 views
  • 21 Apr, 2022
  • 1 location
Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia

End stage liver disease is prone to thrombocytopenia. This study is a multi-center, randomized, prospective, randomized controlled Phase IV Clinical trial to discuss the Efficacy and Safety of

liver disease
platelet count
cirrhosis
avatrombopag
  • 0 views
  • 16 Jun, 2021
  • 1 location
Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis

Immune thrombocytopenia (ITP) is an autoimmune disease but, paradoxically, and unlike other autoimmune diseases, antiplatelet antibodies are not used either for the diagnosis of the disease or

thrombocytopenia
platelet count
platelet aggregation
leukemia
immune globulin
  • 0 views
  • 02 Jun, 2021
  • 1 location
Romiplostim Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

The purpose of this study is to determine the response rate and response duration with the combination of low-dose rituximab, romiplostim and high-dose dexamethasone.

thrombocytopenia
platelet count
rituximab
dexamethasone
romiplostim
  • 2 views
  • 25 Jan, 2021
  • 1 location
Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

This prospective, open-label, single-center, one-arm clinical trial aims at evaluating the efficacy and safety of avatrombopag in Chinese adult Immune Thrombocytopenia (ITP) patients with

thrombocytopenia
platelet count
arthritis
glucocorticoids
eltrombopag
  • 0 views
  • 21 Jul, 2022
  • 1 location
Eltrombopag for Chemotherapy-induced Thrombocytopenia

To evaluate the efficacy and safety of eltrombopag to treat chemotherapy-induced thrombocytopenia in solid tumors

  • 0 views
  • 25 Mar, 2022
  • 1 location
Herombopag for Chemotherapy-induced Thrombocytopenia

To evaluate the efficacy and safety of Herombopag to treat chemotherapy-induced thrombocytopenia in Solid Tumors

  • 0 views
  • 22 Mar, 2022
  • 1 location
Avatrombopag for Chemotherapy-induced Thrombocytopenia

To evaluate the efficacy and safety of Avatrombopag to treat chemotherapy-induced thrombocytopenia in solid tumors

  • 0 views
  • 23 Mar, 2022
  • 1 location
Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

Background Severe aplastic anemia is a rare and serious blood disorder. It happens when the immune system starts to attack the bone marrow cells. This causes the bone marrow to stop making red blood cells, platelets, and white blood cells. Standard treatment for this disease is horse-ATG and cyclosporine, which …

blood disorder
platelet count
white blood cells
anemia
aplastic anemia
  • 115 views
  • 21 Apr, 2022
  • 1 location